BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26920884)

  • 1. The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance.
    Brown NA; Goldman GH
    J Microbiol; 2016 Mar; 54(3):243-53. PubMed ID: 26920884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Steinbach WJ
    Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of hypoxic microenvironments during invasive aspergillosis.
    Wezensky SJ; Cramer RA
    Med Mycol; 2011 Apr; 49 Suppl 1(Suppl 1):S120-4. PubMed ID: 20560863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion stress and antifungal resistance: an Achilles' heel of Aspergillus fumigatus?
    Richie DL; Feng X; Krishnan K; Askew DS
    Med Mycol; 2011 Apr; 49 Suppl 1():S101-6. PubMed ID: 20608779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium signaling pathway is involved in non-CYP51 azole resistance in Aspergillus fumigatus.
    Li Y; Zhang Y; Lu L
    Med Mycol; 2019 Apr; 57(Supplement_2):S233-S238. PubMed ID: 30816964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.
    Wei X; Zhang Y; Lu L
    J Microbiol; 2015 Feb; 53(2):91-9. PubMed ID: 25626363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaping the fungal adaptome--stress responses of Aspergillus fumigatus.
    Hartmann T; Sasse C; Schedler A; Hasenberg M; Gunzer M; Krappmann S
    Int J Med Microbiol; 2011 Jun; 301(5):408-16. PubMed ID: 21565548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery.
    Szalewski DA; Hinrichs VS; Zinniel DK; Barletta RG
    Can J Microbiol; 2018 Jul; 64(7):439-453. PubMed ID: 29586541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillus fumigatus and Aspergillosis in 2019.
    Latgé JP; Chamilos G
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31722890
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Durieux MF; Melloul É; Jemel S; Roisin L; Dardé ML; Guillot J; Dannaoui É; Botterel F
    Virulence; 2021 Dec; 12(1):818-834. PubMed ID: 33682618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management.
    Verweij PE; Zhang J; Debets AJM; Meis JF; van de Veerdonk FL; Schoustra SE; Zwaan BJ; Melchers WJG
    Lancet Infect Dis; 2016 Nov; 16(11):e251-e260. PubMed ID: 27638360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of conidiophore development in Aspergillus fumigatus by an Escherichia coli DH5α strain, a promising antifungal candidate against aspergillosis.
    Balhara M; Ruhil S; Kumar M; Dhankhar S; Chhillar AK
    J Mycol Med; 2014 Mar; 24(1):1-12. PubMed ID: 23978655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
    Verweij PE; Ananda-Rajah M; Andes D; Arendrup MC; Brüggemann RJ; Chowdhary A; Cornely OA; Denning DW; Groll AH; Izumikawa K; Kullberg BJ; Lagrou K; Maertens J; Meis JF; Newton P; Page I; Seyedmousavi S; Sheppard DC; Viscoli C; Warris A; Donnelly JP
    Drug Resist Updat; 2015; 21-22():30-40. PubMed ID: 26282594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
    Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
    Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering cell wall integrity signalling in Aspergillus fumigatus: identification and functional characterization of cell wall stress sensors and relevant Rho GTPases.
    Dichtl K; Helmschrott C; Dirr F; Wagener J
    Mol Microbiol; 2012 Feb; 83(3):506-19. PubMed ID: 22220813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal and host protein persulfidation are functionally correlated and modulate both virulence and antifungal response.
    Sueiro-Olivares M; Scott J; Gago S; Petrovic D; Kouroussis E; Zivanovic J; Yu Y; Strobel M; Cunha C; Thomson D; Fortune-Grant R; Thusek S; Bowyer P; Beilhack A; Carvalho A; Bignell E; Filipovic MR; Amich J
    PLoS Biol; 2021 Jun; 19(6):e3001247. PubMed ID: 34061822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis.
    Ben-Ami R
    Future Microbiol; 2013 Nov; 8(11):1453-62. PubMed ID: 24199803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.
    Ben-Ami R; Lewis RE; Kontoyiannis DP
    Br J Haematol; 2010 Aug; 150(4):406-17. PubMed ID: 20618330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.